NeurogesX Inc (NGSX.PK)

NGSX.PK on OTC Markets Group

0.01USD
1 Aug 2013
Price Change (% chg)

$0.00 (+31.67%)
Prev Close
$0.01
Open
$0.01
Day's High
$0.01
Day's Low
$0.01
Volume
188,699
Avg. Vol
70,694
52-wk High
$0.41
52-wk Low
$0.01

NGSX.PK

Chart for NGSX.PK

About

NeurogesX Inc. (NeurogesX), is a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pains management therapies to address unmet medical needs. Qutenza is the Company's first commercial product, available in the United States and in certain European countries. Qutenza is a... (more)
No analyst recommendations are available for NGSX.PK.

Overall

Beta: 2.15
Market Cap (Mil.): $0.26
Shares Outstanding (Mil.): 33.33
Dividend: --
Yield (%): --

Financials

  NGSX.PK Industry Sector
P/E (TTM): -- 38.06 37.87
EPS (TTM): -0.98 -- --
ROI: -189.10 19.42 18.70
ROE: -- 20.10 19.53
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: S&P Capital IQ Quantitative Report
$58.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$460.00
Provider: GlobalData
$250.00
Provider: ValuEngine, Inc.
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks